Keragon is a technology company.
Keragon has raised $11.0M across 2 funding rounds.
Keragon has raised $11.0M in total across 2 funding rounds.
Keragon is a no-code, AI-powered automation platform purpose-built for healthcare, enabling professionals to connect over 300 software tools—like EHRs (e.g., athenahealth, Healthie, Elation), scheduling systems, and AI scribes—to build HIPAA-compliant workflows without engineering.[1][2][3][4] It serves healthcare organizations of all sizes, from solo practices and mid-sized clinics to large hospitals and digital health startups, solving administrative inefficiencies such as manual patient intake, scheduling, referrals, billing, and data silos that slow care delivery and increase errors.[1][2][4][6] Since launching in June 2024, Keragon has exceeded 100 paying customers, achieved 30% month-over-month growth, and executed over 2 million automations, with customers reporting time savings (e.g., 5 hours/week for one clinic) and revenue gains (e.g., 15% increase).[1][2][3]
Keragon was founded in 2022 in Boston, Massachusetts, by a team of serial tech entrepreneurs and healthcare experts with over 10 years in scaling demanding tech infrastructure, including one prior successful startup acquisition.[1][2][5] CEO and Co-founder Conno Christou leads the deeply technical team, which emerged from stealth in June 2024 with a mission to help healthcare organizations automate securely amid fragmented tools.[2][3][5] Early traction was rapid: within six months of launch, it hit 100+ paying customers and 2 million automations, fueled by demand for HIPAA-compliant integrations that unify disparate systems like EHRs and communication tools.[1][2][3] Pivotal validation came from clinics like Women’s Mental Health Specialists, which streamlined referrals and data transfers, highlighting the platform's real-world impact.[2][3]
Keragon rides the convergence of no-code automation, AI agents, and healthcare digitization, addressing a $4T U.S. industry's administrative burden—where providers lose 15-20 hours/week on manual tasks amid siloed "point solutions."[2][3][6] Timing is ideal post-2024 AI boom and regulatory pushes for interoperability (e.g., via FHIR standards), as fragmented EHRs and telehealth growth demand secure, scalable connectors.[1][4] Market tailwinds include rising digital health adoption and VC interest in compliant infra, evidenced by its $7.5M seed led by Upfront Ventures.[2][3] It influences the ecosystem by reducing barriers for non-technical clinicians, accelerating care delivery, and enabling startups/clinics to compete with enterprises through unified tech stacks.[1][2][6]
Keragon's momentum—30% MoM growth, $7.5M seed, and AI enhancements—positions it to dominate healthcare automation as agentic AI personalizes workflows at scale.[2][3] Next steps include engineering hires, customer success expansion, and deeper AI layers for predictive automations like dynamic scheduling or insurance claims.[2] Trends like multimodal AI, value-based care, and global HIPAA equivalents will amplify its edge, potentially evolving it into a full orchestration hub for health systems. As the first purpose-built player, Keragon transforms fragmentation into connected efficiency, empowering providers to focus on patients over paperwork.[1][2]
Keragon has raised $11.0M in total across 2 funding rounds.
Keragon's investors include Afore Capital, Brighter Capital, Darling Ventures, Gaingels, Imagination Capital, Northside Ventures, Rebel Fund, Uncorrelated Ventures, UpHonest Capital, Y Combinator, Ding Zhou.
Keragon has raised $11.0M across 2 funding rounds. Most recently, it raised $8.0M Seed in February 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2025 | $8.0M Seed | Afore Capital, Brighter Capital, Darling Ventures, Gaingels, Imagination Capital, Northside Ventures, Rebel Fund, Uncorrelated Ventures, UpHonest Capital, Y Combinator, Ding Zhou | |
| Jun 1, 2024 | $3.0M Seed | Afore Capital, Brighter Capital, Darling Ventures, Gaingels, Imagination Capital, Northside Ventures, Rebel Fund, Uncorrelated Ventures, UpHonest Capital, Y Combinator, Ding Zhou |